BREMELANOTIDE | BREMELANOTIDE | ATC G02CX05
MELANOCORTIN RECEPTOR (MCR) AGONIST TREATMENT OF PREMENOPAUSAL WOMEN WITH ACQUIRED, GENERALIZED HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) | SUBCUTANEOUS | Cmax 71 NANOMOLAR Tmax 1 HOUR F 100 PERCENT VD 25 LITER PPB 21 PERCENT Cl 6.5 LITER / HOUR HT 2.7 HOUR | MELANOCORTIN RECEPTOR (MCR) MC1R, MC4R, MC3R, MC5R, MC2R | Melanocortin receptor 4 UNIPROT P32245 MC4R more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |